Vaxcyte prices $750M offering, one of biotech’s largest, as it goes up against Big Pharma’s pneumococcal vaccines

It’ll take a lot of capital and resources to go up against Pfizer, Merck, GSK, Sanofi and others in the pneumococcal vaccine field.

So, San Carlos, CA-based Vaxcyte will seek one of the largest public offerings in…
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks

Advertisement — Advertise with Biotech Networks